Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.
2.

Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.

Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ.

Laryngoscope. 2002 Dec;112(12):2129-40.

PMID:
12461330
3.

Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.

Nathan CO, Franklin S, Abreo FW, Nassar R, De Benedetti A, Glass J.

J Clin Oncol. 1999 Sep;17(9):2909-14.

PMID:
10561370
4.

Prognostic value of cyclin D1 expression in tumor-free surgical margins in head and neck squamous cell carcinomas.

Sakashita T, Homma A, Suzuki S, Hatakeyama H, Kano S, Mizumachi T, Oridate N, Fukuda S.

Acta Otolaryngol. 2013 Sep;133(9):984-91. doi: 10.3109/00016489.2013.795287. Epub 2013 May 22.

PMID:
23692432
5.

Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.

Sunavala-Dossabhoy G, Palaniyandi S, Clark C, Nathan CO, Abreo FW, Caldito G.

Laryngoscope. 2011 Oct;121(10):2136-41. doi: 10.1002/lary.22144. Epub 2011 Sep 6.

PMID:
21898433
6.

Detection of the proto-oncogene eIF4E in larynx and hypopharynx cancers.

Franklin S, Pho T, Abreo FW, Nassar R, De Benedetti A, Stucker FJ, Nathan CO.

Arch Otolaryngol Head Neck Surg. 1999 Feb;125(2):177-82.

PMID:
10037284
7.

Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications.

Nathan CO, Sanders K, Abreo FW, Nassar R, Glass J.

Cancer Res. 2000 Jul 1;60(13):3599-604.

8.

Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.

van Houten VM, Tabor MP, van den Brekel MW, Kummer JA, Denkers F, Dijkstra J, Leemans R, van der Waal I, Snow GB, Brakenhoff RH.

J Pathol. 2002 Dec;198(4):476-86.

PMID:
12434417
10.

Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer.

Nathan CO, Liu L, Li BD, Abreo FW, Nandy I, De Benedetti A.

Oncogene. 1997 Jul 31;15(5):579-84.

11.

The role of molecular margins as prognostic factors in laryngeal carcinoma in Chinese patients.

Yi HJ, Zhang BQ, Guo W, Zhao LD, Yang SM.

Acta Otolaryngol. 2012 Aug;132(8):874-8. doi: 10.3109/00016489.2012.663503. Epub 2012 May 8.

PMID:
22568584
12.

Loss of heterozygosity at 9p and p53 immunopositivity in surgical margins predict local relapse in head and neck squamous cell carcinoma.

Graveland AP, Golusinski PJ, Buijze M, Douma R, Sons N, Kuik DJ, Bloemena E, Leemans CR, Brakenhoff RH, Braakhuis BJ.

Int J Cancer. 2011 Apr 15;128(8):1852-9. doi: 10.1002/ijc.25523.

13.

p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.

Shin DM, Lee JS, Lippman SM, Lee JJ, Tu ZN, Choi G, Heyne K, Shin HJ, Ro JY, Goepfert H, Hong WK, Hittelman WN.

J Natl Cancer Inst. 1996 Apr 17;88(8):519-29.

14.

Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.

Pickhard A, Gröber S, Haug AK, Piontek G, Wirth M, Straßen U, Rudelius M, Reiter R.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jun;117(6):733-42. doi: 10.1016/j.oooo.2014.02.005. Epub 2014 Feb 13.

PMID:
24726415
15.

Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.

Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, Sidransky D.

N Engl J Med. 1995 Feb 16;332(7):429-35.

16.

Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma.

Homann N, Nees M, Conradt C, Dietz A, Weidauer H, Maier H, Bosch FX.

Clin Cancer Res. 2001 Feb;7(2):290-6.

17.

Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.

Schröck A, Bode M, Göke FJ, Bareiss PM, Schairer R, Wang H, Weichert W, Franzen A, Kirsten R, van Bremen T, Queisser A, Kristiansen G, Heasley L, Bootz F, Lengerke C, Perner S.

Carcinogenesis. 2014 Jul;35(7):1636-42. doi: 10.1093/carcin/bgu094. Epub 2014 Apr 17.

18.

[Detection of human papilloma virus DNA and expression of p53 protein in patients with head and neck cancer].

Takano I, Tamura S, Yamanaka N.

Nihon Jibiinkoka Gakkai Kaiho. 1997 May;100(5):524-33. Japanese.

PMID:
9184031
19.

Intraoperative molecular assessment for lymph node metastasis in head and neck squamous cell carcinoma using one-step nucleic acid amplification (OSNA) assay.

Matsuzuka T, Takahashi K, Kawakita D, Kohno N, Nagafuji H, Yamauchi K, Suzuki M, Miura T, Furuya N, Yatabe Y, Matsuo K, Omori K, Hasegawa Y.

Ann Surg Oncol. 2012 Nov;19(12):3865-70. doi: 10.1245/s10434-012-2409-0. Epub 2012 May 23.

PMID:
22618721
20.

A prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-negative breast cancer.

Holm N, Byrnes K, Johnson L, Abreo F, Sehon K, Alley J, Meschonat C, Md QC, Li BD.

Ann Surg Oncol. 2008 Nov;15(11):3207-15. doi: 10.1245/s10434-008-0086-9. Epub 2008 Aug 22.

PMID:
18719964
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk